Remdesivir

Overview

Remdesivir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4065616).

API suppliers (2)

Suppliers of Remdesivir backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• HONOUR LAB LTDIndia1 active DMF
• MAHIMA LIFE SCIENCES PRIVATE LTDIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Remdesivir expires 28 Nov 2041 and exclusivity 13 Jan 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate

Canonical SMILES

CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4

InChIKey

RWWYLEGWBNMMLJ-YSOARWBDSA-N